{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:18:25Z","timestamp":1783448305584,"version":"3.55.0"},"reference-count":38,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":185,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hepatocyte growth factor (HGF)\/c-MET signaling regulates glucose metabolism and tissue remodeling, but its role in gestational diabetes mellitus (GDM) remains unclear. We aimed to investigate maternal serum HGF and soluble c-MET (sc-MET) levels, their tissue expression in placenta and maternal visceral adipose tissue, and their associations with obstetric and perinatal outcomes in GDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective observational, cross-sectional study, 76 pregnant women (32 GDM, 44 normal glucose tolerance) were enrolled. Serum HGF and sc-MET were measured by ELISA; placental and visceral-fat HGF\/c-MET expression was analyzed by RT-PCR and western blot. Clinical variables, including umbilical-cord blood gas and glucose values, were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Maternal sc-MET levels were significantly higher, and cord-blood HGF levels significantly lower, in the GDM group. HGF protein expression was increased in maternal visceral fat but unchanged in placenta. Maternal HGF correlated negatively with cord base excess and positively with lactic acid levels, while cord HGF correlated positively with neonatal glucose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings indicate tissue-specific dysregulation of HGF\/c-MET signaling in GDM, potentially linking maternal insulin resistance with fetal metabolic stress through visceral-fat\u2013derived HGF. The associations between maternal HGF and neonatal lactic acid levels suggest an endocrine interaction influencing fetal adaptation. Further studies are needed to clarify underlying mechanisms across heterogeneous GDM phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Plain language summary<\/jats:title>\n                    <jats:p>GDM is a condition that develops during pregnancy and affects how the body regulates sugar. This study explored how two proteins, HGF and its receptor c-MET, may influence metabolism in mothers with GDM and their babies. Blood, placenta, and visceral fat samples were analyzed from women with and without GDM. Mothers with GDM had higher blood levels of soluble c-MET and lower HGF levels in cord blood. HGF activity was increased in visceral fat, suggesting altered fat metabolism may contribute to insulin resistance. These changes were linked to higher lactic acid levels in newborns, a sign of metabolic stress. The findings suggest that HGF\/c-MET signaling helps coordinate hormonal communication between mother and fetus during pregnancy and could serve as a potential biomarker for maternal insulin resistance and fetal metabolic health in GDM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-25-0560","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T10:28:46Z","timestamp":1765794526000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":0,"title":["Tissue-specific HGF and soluble c-MET levels in gestational diabetes mellitus: insights into maternal\u2013endocrine crosstalk and fetal metabolic adaptation"],"prefix":"10.1530","volume":"15","author":[{"given":"Ye Won","family":"Jung","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Lee","sequence":"additional","affiliation":[{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bok","family":"Ko","sequence":"additional","affiliation":[{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Youn","family":"Song","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon Jong","family":"Yoo","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yea Eun","family":"Kang","sequence":"additional","affiliation":[{"name":"2"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok Soon","family":"Kim","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5037-3225","authenticated-orcid":true,"given":"Byung Hun","family":"Kang","sequence":"additional","affiliation":[{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"2"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"2026070713551355000_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/dmrr.390","article-title":"Intermediate metabolism in normal pregnancy and in gestational diabetes","volume":"19","author":"Di Cianni","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"2026070713551355000_bib2","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","article-title":"Gestational diabetes and the incidence of type 2 diabetes: a systematic review","volume":"25","author":"Kim","year":"2002","journal-title":"Diabetes Care"},{"key":"2026070713551355000_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diaclin.25.2.57","article-title":"Perspectives in gestational diabetes mellitus: a review of screening, diagnosis, and treatment","volume":"25","author":"Perkins","year":"2007","journal-title":"Clin Diabetes"},{"key":"2026070713551355000_bib4","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1080\/00016340802443863","article-title":"Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: current knowledge and metabolic effects on the offspring","volume":"87","author":"Devlieger","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026070713551355000_bib5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/diabetes.48.4.848","article-title":"Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes","volume":"48","author":"Xiang","year":"1999","journal-title":"Diabetes"},{"key":"2026070713551355000_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105405","article-title":"Beta-cell compensation and gestational diabetes","volume":"299","author":"Usman","year":"2023","journal-title":"J Biol Chem"},{"key":"2026070713551355000_bib7","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.3390\/ijms19113342","article-title":"The pathophysiology of gestational diabetes mellitus","volume":"19","author":"Plows","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026070713551355000_bib8","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.3390\/ijms19113467","article-title":"Maternal \u03b2-cell adaptations in pregnancy and placental signalling: implications for gestational diabetes","volume":"19","author":"Moyce","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026070713551355000_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/dmt.10.24","article-title":"Mechanisms in the adaptation of maternal \u03b2-cells during pregnancy","volume":"1","author":"Ernst","year":"2011","journal-title":"Diabetes Manag"},{"key":"2026070713551355000_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fendo.2018.00503","article-title":"The role of hepatocyte growth factor (HGF) in insulin resistance and diabetes","volume":"9","author":"Oliveira","year":"2018","journal-title":"Front Endocrinol"},{"key":"2026070713551355000_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41598-017-00199-4","article-title":"Hepatocyte growth factor prevented high-fat diet-induced obesity and improved insulin resistance in mice","volume":"7","author":"Muratsu","year":"2017","journal-title":"Sci Rep"},{"key":"2026070713551355000_bib12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/diab.43.7.947","article-title":"Hepatocyte growth factor\/scatter factor has insulinotropic activity in human fetal pancreatic cells","volume":"43","author":"Otonkoski","year":"1994","journal-title":"Diabetes"},{"key":"2026070713551355000_bib13","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1074\/jbc.275.2.1226","article-title":"Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia","volume":"275","author":"Garcia-Ocana","year":"2000","journal-title":"J Biol Chem"},{"key":"2026070713551355000_bib14","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1038\/s41467-021-24367-3","article-title":"Structural basis of the activation of c-MET receptor","volume":"12","author":"Uchikawa","year":"2021","journal-title":"Nat Commun"},{"key":"2026070713551355000_bib15","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"2026070713551355000_bib16","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1038\/s41467-021-24367-3","article-title":"Structural basis of the activation of c-MET receptor","volume":"12","author":"Uchikawa","year":"2021","journal-title":"Nat Commun"},{"key":"2026070713551355000_bib17","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/ijc.27861","article-title":"Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: a nested case-control study within the Korean multicenter cancer cohort","volume":"132","author":"Yang","year":"2013","journal-title":"Int J Cancer"},{"key":"2026070713551355000_bib18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.23876\/j.krcp.20.258","article-title":"Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury","volume":"40","author":"Li","year":"2021","journal-title":"Kidney Res Clin Pract"},{"key":"2026070713551355000_bib19","doi-asserted-by":"crossref","first-page":"626578","DOI":"10.1155\/2015\/626578","article-title":"Soluble c-Met is a reliable and sensitive marker to detect c-Met expression level in lung cancer","volume":"2015","author":"Lv","year":"2015","journal-title":"Biomed Res Int"},{"key":"2026070713551355000_bib20","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/1758834011422557","article-title":"c-MET as a potential therapeutic target and biomarker in cancer","volume":"3","author":"Sierra","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"2026070713551355000_bib21","first-page":"28","article-title":"c-MET overexpression as a prognostic biomarker in colorectal adenocarcinoma","volume":"1","author":"Abou-Bakr","year":"2013","journal-title":"Gulf J Oncolog"},{"key":"2026070713551355000_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2337\/db11-1154","article-title":"Loss of HGF\/c-Met signaling in pancreatic \u03b2-cells leads to incomplete maternal \u03b2-cell adaptation and gestational diabetes mellitus","volume":"61","author":"Demirci","year":"2012","journal-title":"Diabetes"},{"key":"2026070713551355000_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9440(10)62987-2","article-title":"\u03b2-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance","volume":"167","author":"Dai","year":"2005","journal-title":"Am J Pathol"},{"key":"2026070713551355000_bib24","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes \u2013 2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","journal-title":"Diabetes Care"},{"key":"2026070713551355000_bib25","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/1878-0261.12939","article-title":"The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker","volume":"15","author":"Klotz","year":"2021","journal-title":"Mol Oncol"},{"key":"2026070713551355000_bib26","doi-asserted-by":"crossref","first-page":"E843","DOI":"10.1152\/ajpendo.00174.2006","article-title":"Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity","volume":"291","author":"Bell","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026070713551355000_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJMMR\/2015\/18632","article-title":"Early pregnancy maternal hepatocyte growth factor and risk of gestational diabetes","volume":"9","author":"Dishi","year":"2015","journal-title":"Br J Med Med Res"},{"key":"2026070713551355000_bib28","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0735-1097(03)00231-6","article-title":"Obesity is associated with increased levels of circulating hepatocyte growth factor","volume":"41","author":"Rehman","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026070713551355000_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.23736\/S0391-1977.20.03192-2","article-title":"The possible role of endocrine dysfunction of adipose tissue in gestational diabetes mellitus","volume":"45","author":"\u0160imj\u00e1k","year":"2020","journal-title":"Minerva Endocrinol"},{"key":"2026070713551355000_bib30","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.3390\/ijms19113467","article-title":"Maternal \u03b2-cell adaptations in pregnancy and placental signalling: implications for gestational diabetes","volume":"19","author":"Moyce","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026070713551355000_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.prrv.2012.02.002","article-title":"Respiratory distress of the term newborn infant","volume":"14","author":"Edwards","year":"2013","journal-title":"Paediatric Respir Rev"},{"key":"2026070713551355000_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000091663","article-title":"Consistent expression of HGF and c-Met in the perinatal lung","volume":"90","author":"Lassus","year":"2006","journal-title":"Biol Neonate"},{"key":"2026070713551355000_bib33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/ajrccm.162.2.9908064","article-title":"Enhanced expression of hepatocyte growth factor by pulmonary ischemia\u2013reperfusion injury in the rat","volume":"162","author":"Yamada","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026070713551355000_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1067\/S0022-3476(03)00297-X","article-title":"Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants","volume":"143","author":"Lassus","year":"2003","journal-title":"J Pediatr"},{"key":"2026070713551355000_bib35","doi-asserted-by":"crossref","first-page":"1462841","DOI":"10.3389\/fcell.2024.1462841","article-title":"Lung epithelial-endothelial-mesenchymal signaling network with hepatocyte growth factor as a hub is involved in bronchopulmonary dysplasia","volume":"12","author":"Sang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"2026070713551355000_bib36","first-page":"321","article-title":"Placental-fetal glucose exchange and fetal glucose metabolism","volume":"117","author":"Hay","year":"2006","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2026070713551355000_bib37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1507\/endocrj.EJ22-0521","article-title":"Risk factors of neonatal hypoglycemia in neonates born to mothers with gestational diabetes","volume":"70","author":"Arimitsu","year":"2023","journal-title":"Endocr J"},{"key":"2026070713551355000_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.placenta.2015.01.199","article-title":"Hepatocyte growth factor is elevated in amniotic fluid from obese women and regulates placental glucose and fatty acid metabolism","volume":"36","author":"Visiedo","year":"2015","journal-title":"Placenta"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/15\/1\/EC-25-0560.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/15\/1\/EC-25-0560.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0560\/504951\/ec-25-0560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0560\/504951\/ec-25-0560.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:55:20Z","timestamp":1783446920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/1\/e250560\/75424\/Tissue-specific-HGF-and-soluble-c-MET-levels-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0560","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"article-number":"e250560"}}